Published in Clinical Oncology Week, May 16th, 2005
New investors, including Siemens Venture Capital GmbH, Corp., Tudor Investment Corp., MedCap Management & Research LLC, and Emigrant Capital Corp. joined existing institutional and individual investors in the financing round. SG Cowen & Co. served as placement agent.
"BMIPP has great potential to be the first product to enable...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.